Charcot-Marie-Tooth Disease Axonal Type 2O (CMT2O)

Charcot-Marie-Tooth disease axonal type 2O (CMT2O) is a very rare inherited nerve disease that mainly affects the long nerves going to the feet and hands. Doctors call this a “hereditary motor and sensory neuropathy,” which means that both movement (motor) and feeling (sensory) nerves are slowly damaged over many years. In CMT2O, the problem is in the axon, which is the long “wire-like” part of the nerve cell that carries electrical signals. Because the axon is injured, the signals between the brain, spinal cord, and muscles become weak. This causes muscle weakness, muscle wasting, balance problems, and loss of feeling, especially in the lower legs and feet, and later sometimes in the hands. NCBI+1

Charcot-Marie-Tooth disease axonal type 2O (CMT2O) is a rare inherited nerve disease. It mainly damages the long “wires” (axons) of the peripheral nerves that carry signals to and from the feet, legs, hands, and arms. In CMT2O, a change (mutation) in a gene called DYNC1H1 affects how nerve cells move important proteins and organelles along the axon, so the nerve slowly becomes weak and cannot send signals properly.National Organization for Rare Disorders+1

CMT2O is usually autosomal dominant, which means a person can get the condition if they inherit one changed copy of the gene from either parent. Symptoms often begin in childhood or early adult life and include foot deformities (such as high arches or hammer toes), weakness in the feet and lower legs, difficulty running, frequent tripping, and reduced feeling in the feet. Over time, weakness can move upward and sometimes affect the hands. The disease is usually slowly progressive, and most people live a normal life span.MalaCards+1

CMT2O is usually caused by a harmful change (mutation) in a gene called DYNC1H1, which gives instructions for a large protein (cytoplasmic dynein) that helps move important materials inside nerve cells. When this protein does not work properly, the nerve cannot maintain its long axon, and over time the nerve fibres slowly degenerate. Because the gene change is present from birth, the condition is lifelong. However, symptoms often start in childhood and progress slowly, and many people can still walk in adult life. MalaCards+1

CMT2O is usually inherited in an autosomal dominant way. This means a person only needs one altered copy of the gene (from either mother or father) to have the disease. In some people, the mutation can be new (de novo), which means it appears for the first time in that person and was not present in either parent. Families may show a range of severity; some relatives may have mild symptoms while others are more affected. MalaCards+1

This disease is extremely rare, with fewer than one in a million people affected. It is one specific subtype of Charcot-Marie-Tooth type 2 (CMT2), which is the axonal group of CMT. CMT2 itself is a larger family of conditions with many different genes, but CMT2O is the subtype linked to DYNC1H1. GARD Information Center+1

Other names

CMT2O has several other names used in medical books and genetic databases. These names all describe the same condition, just with slightly different wording. MalaCards+1

• Charcot-Marie-Tooth disease, axonal, type 2O

• Charcot-Marie-Tooth disease axonal type 2O

• CMT2O

• Charcot-Marie-Tooth neuropathy axonal type 2O

• Autosomal dominant Charcot-Marie-Tooth disease type 2O

• Charcot-Marie-Tooth disease caused by mutation in DYNC1H1

• DYNC1H1-related Charcot-Marie-Tooth disease

• DYNC1H1-related neuromuscular disorder with CMT2O pattern

Types

Doctors do not officially divide CMT2O into fixed “types” like type A, B, or C. However, when they look at real patients and families, they see some patterns. These patterns can be described as clinical forms or presentations inside the same genetic disease. NCBI+1

One clinical form is a pure neuromuscular CMT2O form. In this pattern, people mainly have problems in the peripheral nerves to the legs and arms, with weakness, wasting, and sensory loss, but the brain and thinking ability are normal. Symptoms start in childhood with toe-walking, frequent tripping, and slowly increasing foot deformities such as high-arched feet (pes cavus). GARD Information Center+1

A second pattern is CMT2O with skeletal and joint problems. In this group, the nerve damage is combined with joint stiffness or contractures, such as clubfoot, claw toes, or arthrogryposis (stiff joints present from birth). Some people also develop scoliosis, which is a sideways curve of the spine. These features reflect long-standing muscle imbalance and weakness. GARD Information Center+1

A third pattern is CMT2O with central nervous system involvement. In a subset of DYNC1H1-related patients, in addition to the peripheral neuropathy, there may be intellectual disability, learning problems, epilepsy, or spasticity (stiff muscles due to involvement of brain pathways). This wider picture is sometimes grouped under “DYNC1H1-related neurodevelopmental disorder,” but the peripheral nerve findings are still similar to CMT2O. NCBI+1

A fourth pattern is mild or late-onset CMT2O. In some individuals, symptoms are quite mild or start later, so they may only notice slight weakness, balance issues, or mild foot deformities in adulthood. These people might be diagnosed only after a more severely affected child or relative is tested, showing how variable the same gene mutation can be. NCBI+1

Finally, there is a severe early-onset CMT2O form. In this pattern, children show significant motor delay, difficulty walking, and more rapid progression of weakness from early life. Some may need walking aids or wheelchairs earlier, and orthopaedic problems such as scoliosis can develop sooner. Even in these severe cases, progression is usually slow over many years, not sudden. GARD Information Center+1

Causes

Remember that the main true cause of CMT2O is a genetic mutation in the DYNC1H1 gene. Many of the “causes” below are best understood as mechanisms or risk factors that explain how the gene mutation leads to nerve damage, or factors that can worsen the course of the disease, rather than separate external causes.

1. DYNC1H1 gene mutation – The primary cause of CMT2O is a harmful change in one copy of the DYNC1H1 gene. This gene encodes the heavy chain of cytoplasmic dynein, a motor protein that moves cargo along microtubules inside cells. When this protein is faulty, long peripheral nerves cannot move nutrients and waste products properly, leading to slow axonal degeneration. MalaCards+1

2. Autosomal dominant inheritance – Because this condition is autosomal dominant, a parent with the mutation has a 50% chance in each pregnancy to pass it to their child. This inheritance pattern explains why CMT2O often appears in multiple members across several generations of a family. MalaCards+1

3. De novo (new) mutations – In some people, the DYNC1H1 mutation appears for the first time, without a family history. This happens because the gene change arises in the egg or sperm or early embryo. This explains why some patients have the disease even when their parents seem unaffected. nature.com+1

4. Disrupted axonal transport – Cytoplasmic dynein is essential for moving cell parts, proteins, and mitochondria up and down the axon. When dynein is abnormal, axonal transport slows or fails. Over time, the axon cannot stay healthy, leading to length-dependent nerve fibre loss that shows first in the longest nerves to the feet. nature.com+1

5. Length-dependent axonal degeneration – Because the longest nerves are most vulnerable, damage starts in the distal legs and later affects the hands. This characteristic “dying-back” pattern is a direct result of disturbed axonal transport over long distances. Europe PMC+1

6. Mitochondrial stress in neurons – Experiments suggest that disturbed dynein function can affect mitochondrial movement and energy supply in neurons. If nerve cells do not get enough energy, they become more sensitive to stress and may degenerate sooner. MDPI+1

7. Secondary myelin changes – Even though CMT2O is an axonal neuropathy, long-standing axonal damage can secondarily affect the myelin sheath. This does not turn it into a primary demyelinating CMT, but it can worsen nerve conduction and symptoms. NCBI+1

8. Modifier genes – Other genes besides DYNC1H1 may modify how severe the disease is. They may influence how well axons repair themselves or how resilient they are to transport problems. This helps explain why two people with the same DYNC1H1 mutation can have different levels of disability. MDPI+1

9. Age-related nerve vulnerability – As people age, all nerves naturally face more wear and tear. In someone with CMT2O, the mutant gene makes nerves more fragile, so age-related changes can uncover or worsen symptoms. ResearchGate+1

10. Mechanical stress on feet and ankles – Because of abnormal muscle balance, the feet are often deformed. Abnormal pressure and repeated minor injuries can contribute to pain, calluses, and further difficulty walking, which can make the neuropathy more disabling, though they do not create the disease itself. ResearchGate+1

11. Poorly controlled diabetes (co-morbid factor) – If a person with CMT2O also develops diabetes, the high blood sugar can damage nerves further, adding diabetic neuropathy on top of hereditary neuropathy. This co-morbidity can increase numbness and pain, but diabetes is not the primary cause of CMT2O. Muscular Dystrophy Association+1

12. Exposure to neurotoxic drugs – Certain chemotherapy agents or strong antibiotics can be toxic to peripheral nerves. In someone who already has DYNC1H1-related nerve weakness, these drugs may cause faster worsening, so neurologists try to avoid such medicines when possible. PMC+1

13. Alcohol misuse – Heavy, long-term alcohol intake can cause an additional toxic neuropathy. In people with CMT2O, this may lead to earlier need for walking aids or more severe balance problems. NCBI+1

14. Nutritional deficiencies – Lack of vitamins such as B12, B1, or folate can damage nerves. If a person with CMT2O also has these deficiencies, symptoms may be more pronounced. Treating the deficiency does not remove the genetic disease but can improve nerve function somewhat. NCBI+1

15. Repeated ankle sprains and injuries – Weak ankle muscles and poor sensation make sprains common. Each injury can lead to more joint instability and deformity, which in turn makes walking harder and increases the feeling of disability. Orthobullets+1

16. Spinal deformity (scoliosis) – When back muscles are weak and imbalanced, scoliosis can develop. This can shift body weight and further stress already weak leg muscles. It is part of the disease picture rather than a separate cause, but it adds to functional problems. GARD Information Center+1

17. Reduced physical activity – Because walking becomes harder, some people naturally move less. Low activity can lead to general deconditioning and loss of remaining strength, making CMT2O feel worse than it might if muscles were kept as active as safely possible. Physiopedia+1

18. Obesity as a load factor – Extra body weight increases the load on weak feet and ankles and may worsen pain and fatigue. While obesity does not cause the genetic disease, it can reduce mobility and independence. NCBI+1

19. Unaddressed orthopaedic problems – If pes cavus, claw toes, or contractures are not supported by braces or surgery when needed, walking may become more difficult, and falls and injuries may increase. Again, this does not cause CMT2O but worsens its impact. Orthobullets+1

20. Lack of early diagnosis and support – When CMT2O remains undiagnosed, children may not get physiotherapy, orthotics, or school accommodations. This can lead to avoidable complications, such as more severe deformities and reduced participation in activities, which can make the long-term outcome poorer. ScienceDirect+1

Symptoms

1. Slowly progressive distal leg weakness – The most common early symptom is weakness in the muscles around the ankles and feet. Children may have trouble running, hopping, or climbing stairs. Over time, lifting the front of the foot becomes difficult, which is known as foot drop. The weakness is usually slowly progressive rather than sudden. GARD Information Center+1

2. Muscle wasting in lower legs – Because the nerves cannot properly activate muscles, the muscles shrink (atrophy). The lower legs may look thin and “inverted bottle” or “stork-like.” This wasting makes it even harder to stand on toes or heels and reduces endurance for walking. NCBI+1

3. Pes cavus (high-arched feet) – Many people with CMT2O develop high-arched, rigid feet with clawed toes. This deformity is due to a long-term imbalance between weaker muscles and relatively stronger ones in the foot. Pes cavus increases pressure on the ball of the foot and heel, causing calluses and pain. GARD Information Center+1

4. Delayed motor milestones – In early-onset cases, children may sit, stand, or walk later than usual. They may be described as clumsy or slow compared with other children, needing support for longer when learning to walk. GARD Information Center+1

5. Abnormal gait and frequent tripping – Weak ankle muscles and poor sensation in the feet often cause unsteady walking. Patients may have a high-stepping gait to avoid dragging the toes. They may trip over small obstacles and fall more often than friends or siblings. GARD Information Center+1

6. Distal sensory loss – Loss of feeling often affects vibration, light touch, and position sense in the feet. People may not feel small injuries or may feel numbness or tingling (pins and needles). This loss of feedback contributes to balance problems. NCBI+1

7. Reduced or absent ankle reflexes – On neurological examination, doctors often find that ankle tendon reflexes are weak or absent. This is a typical feature of many types of Charcot-Marie-Tooth disease and reflects damage to peripheral nerves. NCBI+1

8. Weakness in distal hands – As the disease progresses, the nerves to the hands can also be affected. People may notice difficulty with fine tasks such as buttoning clothes, opening jars, or writing for a long time. Hand muscles can become thin, especially between the thumb and index finger. NCBI+1

9. Muscle cramps and fatigue – Weak and overworked muscles can cramp easily, particularly after long periods of walking or standing. Fatigue is common because the body must work harder to move weak muscles and maintain balance. NCBI+1

10. Foot and ankle pain – Pain may result from joint strain, abnormal pressure from pes cavus, or repeated sprains due to instability. Some patients also experience neuropathic pain, such as burning or shooting sensations, due to irritated nerves. Life in the Fast Lane • LITFL+1

11. Scoliosis (curved spine) – In some individuals, especially with early and significant muscle imbalance, the spine develops a sideways curve. This scoliosis may cause back pain and can further affect posture and balance. GARD Information Center+1

12. Joint contractures or arthrogryposis – Stiff joints in the feet, ankles, or other areas can occur, especially when weakness is present from birth or early life. Arthrogryposis refers to joints that are fixed in a bent or straight position, making movement limited. GARD Information Center+1

13. Spasticity in some patients – In a subset of people with DYNC1H1 mutations, there is involvement not only of peripheral nerves but also of brain pathways that control movement. This can cause muscle stiffness, increased reflexes, or scissoring of the legs while walking, combining features of CMT and upper motor neuron signs. NCBI+1

14. Cognitive or learning difficulties (in some) – Some DYNC1H1-related patients show mild intellectual disability, language delay, or learning problems. This is not present in everyone, but it reflects that the same gene is important for brain development as well as for peripheral nerves. NCBI+1

15. Psychosocial impact – Living with a visible disability, walking aids, or foot deformities can lead to low self-esteem, anxiety, or social withdrawal, especially in teenagers. Fatigue and pain may also affect school, work, and daily activities. Psychological support and good information can help people cope better. ResearchGate+1

Diagnostic tests

Doctors diagnose CMT2O by combining the story (history), examination, nerve tests, and genetic testing. Most tests are used to confirm a hereditary neuropathy and exclude other causes; genetic tests identify CMT2O specifically.

1. Comprehensive neurological physical exam (physical exam) – A neurologist examines muscle strength, tone, reflexes, sensation, and coordination. They look for distal weakness, muscle wasting in the lower legs, reduced ankle reflexes, and sensory loss. The pattern of these signs, plus family history, strongly suggests a hereditary neuropathy such as CMT2O. NCBI+1

2. Gait and balance assessment (physical exam) – The doctor observes how the person walks, runs, and turns. They may ask the patient to walk on heels or toes or along a straight line. A high-stepping gait, foot drop, and difficulty walking on heels are typical for CMT. Balance tests (such as standing with feet together and eyes closed) show how sensory loss affects stability. Orthobullets+1

3. Inspection of feet and spine (physical exam) – The clinician looks for high arches, claw toes, calluses, ankle instability, and scoliosis. These visible deformities support a long-standing neuropathy and help distinguish CMT2O from conditions that start later in life. Orthobullets+1

4. Manual muscle testing using MRC scale (manual test) – Each muscle group is graded from 0 (no movement) to 5 (normal strength). This structured test documents how weak distal muscles are compared with proximal ones and tracks progression over time. In CMT2O, distal muscles in the legs typically have lower scores. Springer Nature Link+1

5. Bedside sensory testing (manual test) – Using simple tools such as cotton, a pin, or tuning fork, the doctor checks touch, pain, vibration, and position sense. Loss of vibration and position sense in the toes and ankles is common in CMT and supports peripheral nerve involvement. NCBI+1

6. Romberg test (manual test) – The patient stands with feet together and then closes their eyes. If they sway or lose balance significantly without visual input, this suggests sensory ataxia from impaired position sense in the feet, which is often seen in hereditary neuropathies. NCBI+1

7. Functional walking tests (manual test) – Timed tests such as the 10-meter walk or six-minute walk test measure walking speed and endurance. These tests help quantify disability and monitor response to rehabilitation or orthotic support in people with CMT2O. ResearchGate+1

8. Basic blood tests (lab/pathological) – Tests such as full blood count, blood sugar, thyroid function, vitamin B12 level, and kidney and liver function help rule out other common causes of neuropathy (for example, diabetes or vitamin deficiency). In CMT2O, these tests are usually normal, which supports a hereditary cause. PMC+1

9. Serum creatine kinase (CK) (lab/pathological) – CK is an enzyme released from damaged muscle. In CMT, CK is often normal or only mildly raised, which helps distinguish it from primary muscle diseases in which CK may be very high. NCBI+1

10. Nerve conduction studies (NCS) (electrodiagnostic) – This key test uses small electrical pulses to measure how fast and how strongly nerves conduct signals. In CMT2O, conduction velocities are usually normal or only slightly reduced, indicating an axonal neuropathy, while the amplitudes (size of responses) may be low because many axons are lost. This pattern helps separate CMT2 from demyelinating CMT1. PMC+1

11. Electromyography (EMG) (electrodiagnostic) – EMG involves placing fine needles into muscles to record electrical activity. In CMT2O, EMG shows signs of chronic denervation and reinnervation, such as large motor units, which confirm that the problem is in the nerves that supply the muscles. PMC+1

12. F-wave studies (electrodiagnostic) – F-waves are late responses used to test the entire length of motor nerves. In axonal CMT2, F-wave latency may be prolonged if many axons are affected, helping to confirm generalized peripheral nerve involvement. PMC+1

13. Somatosensory evoked potentials (SSEPs) (electrodiagnostic) – SSEPs measure how sensory signals from the limbs travel to the brain. They may show delayed or reduced responses in hereditary neuropathies, especially when sensory loss is marked, and can sometimes reveal additional central involvement in DYNC1H1-related disorders. NCBI+1

14. Targeted genetic test for DYNC1H1 (lab/genetic) – A blood or saliva sample is analysed to look for mutations in the DYNC1H1 gene. Finding a clearly disease-causing variant in a person with typical symptoms confirms CMT2O. Genetic testing also allows testing of at-risk relatives and counselling for family planning. MalaCards+1

15. CMT or neuropathy gene panel (lab/genetic) – Many centres use next-generation sequencing panels that test dozens of CMT-related genes at once, including DYNC1H1. This is useful when the clinical picture suggests CMT2 but the exact subtype is not obvious. Identifying the gene helps with prognosis and genetic counselling. Mayo Clinic Laboratories+1

16. Whole exome or genome sequencing (lab/genetic) – If standard panels do not find a mutation, broader sequencing may be used. CMT2O was first discovered by exome sequencing in a family with axonal CMT. Today, exome or genome sequencing may help detect rare or new DYNC1H1 variants. ScienceDirect+1

17. Nerve biopsy (lab/pathological) – A small piece of peripheral nerve (often sural nerve) may be taken and examined under the microscope. In axonal CMT, biopsy shows loss of axons with relatively preserved myelin. Because genetic testing is now widely available, nerve biopsy is reserved for unclear cases or when other diagnoses are suspected. PMC+1

18. Foot and spine X-rays (imaging) – X-rays of the feet can show high arches, claw toes, and joint changes, helping surgeons plan corrective procedures. Spine X-rays reveal scoliosis and measure its degree. These images do not show the nerves, but they document skeletal complications of long-standing neuropathy. ResearchGate+1

19. Muscle MRI or ultrasound (imaging) – Imaging of leg muscles can show patterns of muscle wasting and fat replacement typical of certain neuropathies. In CMT2O, distal leg muscles often show more severe changes. This can help distinguish neuropathic from myopathic (primary muscle) conditions. MDPI+1

20. Brain and spinal cord MRI (imaging) – In patients with suspected central involvement (such as seizures, spasticity, or intellectual disability), MRI of the brain and spine helps rule out other causes and may show subtle abnormalities in DYNC1H1-related neurodevelopmental disorders. Although MRI findings are often normal or non-specific, this test is important when symptoms go beyond pure peripheral neuropathy. NCBI+1

Non-pharmacological treatments

1. Physiotherapy (physical therapy)
   Physiotherapy is one of the most important non-drug treatments for CMT2O. A physiotherapist designs gentle exercises to keep muscles strong, joints flexible, and posture stable. Regular stretching and strengthening help slow stiffness and weakness, lower the risk of falls, and maintain walking ability for as long as possible.nhs.uk+2Physiopedia+2

2. Progressive resistance exercise
   Progressive resistance exercise uses light weights or bands that slowly increase over time. In carefully supervised programs, this can preserve or improve strength in key muscles such as ankle dorsiflexors (muscles that lift the foot) without harming nerves. This helps walking, standing, and daily activities like climbing stairs.ScienceDirect+2PubMed+2

3. Aerobic (cardio) exercise
   Low-impact aerobic activities, such as walking on flat ground, cycling, or swimming, improve stamina, heart health, and mood. In CMT, regular aerobic training can support overall function and may reduce fatigue and deconditioning, as long as intensity is adjusted to the person’s abilities and symptoms.PubMed+1

4. Stretching and contracture prevention
   Daily stretching of ankles, calves, hamstrings, and hands helps prevent contractures (permanent joint stiffness) and tendon shortening. Simple stretches held for 20–30 seconds, repeated several times, can keep joints moving freely and reduce pain linked to tight muscles and abnormal foot shape.nhs.uk+2Physiopedia+2

5. Balance and proprioception training
   Balance exercises such as standing on one leg with support, using balance boards, or doing safe weight-shifting tasks help the brain and body adjust to weak and numb feet. Stronger balance reduces falls and injuries, which are common in people with foot drop and sensory loss.Physiopedia+2PMC+2

6. Gait training and walking re-education
   A physiotherapist can teach safer walking patterns, turning movements, and strategies for stairs. They may use treadmills, visual cues, or metronomes to help timing and step length. Gait training adapts to each person’s deformities and helps conserve energy while walking.PMC+2PubMed+2

7. Ankle-foot orthoses (AFOs)
   AFOs are lightweight braces worn in shoes to hold the ankle at a good angle and prevent the toes from dragging (foot drop). They improve walking safety, reduce tripping, and support weak muscles. The style of brace is chosen based on deformity, strength, and comfort.PMC+2ScienceDirect+2

8. Custom footwear and insoles
   Special shoes and insoles can spread pressure more evenly, correct mild deformities, and protect numb skin from blisters. High-top shoes may support weak ankles. Early use of proper footwear can delay or reduce the need for surgery in people with cavus (high-arched) feet.PMC+2ScienceDirect+2

9. Occupational therapy (OT)
   Occupational therapists help people adapt daily tasks like dressing, writing, cooking, and computer use. They may suggest adaptive tools (button hooks, grip aids, modified keyboards) so the person can stay independent at school, work, and home despite hand weakness or numbness.PMC+2PubMed+2

10. Hand therapy and fine-motor training
    Targeted exercises for the hands strengthen small muscles and improve coordination. Activities such as putty exercises, peg boards, or specific grip tasks help maintain the ability to hold pens, use a phone, and manage zippers and buttons.PMC+1

11. Hydrotherapy (water-based therapy)
    Exercise in warm water supports the body and lowers stress on weak joints and muscles. People who struggle on land can often walk, stretch, and strengthen more comfortably in a pool, which may improve confidence and overall activity levels.PMC+1

12. Pain-management physiotherapy
    Specific manual therapy, massage, gentle joint mobilization, and relaxation techniques can help non-neuropathic pain caused by joint stress or poor posture. Combined with stretching and posture training, physiotherapy can reduce back and foot pain linked to deformity.PMC+2PMC+2

13. Podiatry and foot care
    Regular visits to a podiatrist help manage calluses, nail problems, and pressure areas in numb feet. Early treatment of small skin injuries lowers the risk of infections and ulcers, which can be serious when sensation is reduced.PMC+2PMC+2

14. Fall-prevention and home safety programs
    Assessing the home for loose rugs, poor lighting, or unsafe stairs and adding grab bars or railings can greatly reduce falls. Simple changes like non-slip mats and bed-side lights make movement safer, especially at night.PMC+2PubMed+2

15. Respiratory and posture monitoring (in severe cases)
    Some people with CMT develop scoliosis or chest muscle weakness. Monitoring posture and breathing function, and using breathing exercises or devices if needed, helps prevent complications such as reduced lung capacity or chronic back pain.PMC+1

16. Psychological support and counseling
    Living with a progressive genetic disease can cause anxiety, sadness, or low confidence. Counseling, cognitive behavioral therapy, and peer support groups help people cope with stress, adapt to physical changes, and maintain good mental health.PMC+2PubMed+2

17. Vocational and educational support
    Occupational therapists and social workers can help adjust school or work tasks to match physical abilities, provide ergonomic advice, and suggest accommodations (modified desks, flexible schedules) so people can stay active in studies and careers.PMC+1

18. Patient and family education
    Education about CMT2O, inheritance, and symptom management helps families plan and avoid harmful activities, such as certain toxic drugs or unsafe sports. Understanding the condition also encourages earlier use of braces and therapy, which improves long-term function.PMC+2PubMed+2

19. Genetic counseling
    Genetic counselors explain the autosomal dominant inheritance pattern and options for family planning. They help relatives decide whether to be tested and support them in understanding what the results mean for future pregnancies and life planning.MalaCards+2Frontiers+2

20. Participation in clinical trials
    For some people with CMT (including DYNC1H1-related forms), clinical trials are testing new drugs and other therapies. Joining a trial may give access to new options and also helps researchers find future treatments, but risks and benefits must be carefully discussed with specialists.DYNC1H1 Association+2PubMed+2

---

Drug treatments

Reminder: No drug is currently approved specifically and only for CMT2O. Medicines are used to treat symptoms such as neuropathic pain, muscle spasms, or mood problems, often based on general neuropathy guidelines. Always follow a doctor’s advice and the official FDA label.

1. Gabapentin
   Gabapentin is an anti-seizure medicine widely used for neuropathic pain. It calms over-active nerve signals by binding to certain calcium channels in the nervous system. FDA labels show it is approved for conditions like post-herpetic neuralgia, and doses are slowly increased to balance pain relief and side effects such as dizziness and sleepiness.FDA Access Data+2FDA Access Data+2

2. Pregabalin
   Pregabalin is related to gabapentin and also targets calcium channels to reduce nerve pain. It is approved for several neuropathic conditions and generalized anxiety in adults. Doctors usually start with a low dose and adjust based on pain control and tolerability, watching for side effects such as drowsiness, weight gain, or swelling.PubMed+1

3. Duloxetine
   Duloxetine is an SNRI antidepressant that increases serotonin and noradrenaline levels, chemicals that modulate pain pathways in the brain and spinal cord. It is FDA-approved for diabetic peripheral neuropathic pain and depression. In CMT-related neuropathic pain, it is often used off-label with careful monitoring for nausea, dry mouth, or mood changes.PMC+1

4. Amitriptyline
   Amitriptyline is a tricyclic antidepressant that blocks re-uptake of serotonin and noradrenaline and also has local pain-modulating effects. Low bedtime doses can reduce burning or shooting neuropathic pain and improve sleep. Side effects include dry mouth, constipation, and drowsiness, so doctors adjust doses slowly and avoid use in some heart conditions.PMC+1

5. Nortriptyline
   Nortriptyline is similar to amitriptyline but sometimes better tolerated. It is used off-label for neuropathic pain in many conditions. It works by altering pain signaling in the central nervous system. Doctors balance benefit and risk by titrating doses and monitoring for heart rhythm issues and anticholinergic effects.PMC+1

6. Carbamazepine or oxcarbazepine
   These anti-seizure drugs stabilize nerve membranes and are classically used for trigeminal neuralgia. In some people with severe shooting or electric shock–like pains, specialists may try them off-label, slowly adjusting doses and checking blood counts and sodium levels to avoid adverse effects.PMC+1

7. Topical lidocaine (patches or gel)
   Lidocaine is a local anesthetic that blocks sodium channels in skin nerves, reducing pain signals from a limited area. Lidocaine 5% patches are approved for post-herpetic neuralgia and are sometimes used over the most painful parts of the feet. They provide local relief with minimal systemic side effects when used correctly.PMC+1

8. Topical capsaicin
   Capsaicin cream or high-strength patches come from chili peppers and deplete “substance P,” a pain-signal chemical in nerve endings. After an initial burning sensation, repeated use can reduce chronic neuropathic pain in some people. Skin irritation is the main side effect, so application technique and area size must be supervised.PMC+1

9. Non-steroidal anti-inflammatory drugs (NSAIDs)
   Medicines like ibuprofen or naproxen do not fix nerve damage but can relieve musculoskeletal pain from joint deformities, overuse, or arthritis that often accompany CMT. Doctors recommend the lowest effective dose for the shortest time to reduce stomach, kidney, or heart risks, especially in older adults.PMC+1

10. Acetaminophen (paracetamol)
    Acetaminophen is often used for mild to moderate non-neuropathic pain and has fewer stomach side effects than NSAIDs. It is useful for background pain from muscle strain or joint stress. Total daily dose must stay within safe limits to avoid liver damage, especially when combined with other medicines containing acetaminophen.PMC+1

11. Short-term tramadol (with caution)
    Tramadol has both weak opioid action and serotonin/noradrenaline re-uptake inhibition. Some doctors use it for short periods when neuropathic pain is severe and other drugs are not enough. Because of risks of dependence, dizziness, and serotonin syndrome, it must be carefully monitored and is not a first-line long-term option.PMC+1

12. Muscle relaxants (for cramps/spasms)
    Medicines such as baclofen or tizanidine may be used if there is significant muscle spasm or spasticity. They act on the spinal cord to reduce over-active muscle reflexes. Doses are titrated slowly to avoid weakness, sedation, or dizziness, and they are usually reserved for selected cases.PMC+1

13. Sleep-support medications (short-term)
    Severe pain and discomfort can disturb sleep. In some people, short-term use of sedating antidepressants or other sleep aids is considered, alongside good sleep hygiene and non-drug strategies. Doctors choose options with the lowest risk of dependence or worsening daytime fatigue.PMC+1

14. Antidepressants for mood disorders
    Living with chronic pain and disability increases the risk of depression and anxiety. SSRIs or SNRIs are prescribed when needed, not only to manage mood but also to improve coping and pain perception. Choice of drug depends on age, other medicines, and individual side-effect patterns.PMC+2PubMed+2

15. Anxiolytics in selected cases
    Very short-term use of anti-anxiety medicines may be considered for severe anxiety or procedures, but non-drug therapies are preferred. Long-term use can cause dependence and cognitive problems, so doctors are cautious and monitor closely if these medicines are prescribed.PMC+1

16. Vitamin B12 injections (if deficient)
    If blood tests show vitamin B12 deficiency, replacement with injections or high-dose oral supplements is essential, as low B12 itself can cause neuropathy. Correcting deficiency does not cure CMT2O but can prevent extra nerve damage from another cause.PMC+1

17. Pain-modulating combinations
    In practice, doctors often combine two different classes of pain-modulating drugs (for example, gabapentin plus duloxetine) at modest doses rather than high doses of one drug. This can provide better pain relief with fewer side effects, but must always be supervised by a specialist.PMC+1

18. Drugs under trial for CMT
    Several drugs, such as ion-channel modulators and HDAC6 inhibitors, are in clinical trials to improve nerve function in CMT. These medicines are not yet approved but represent important research directions. Participation is only through controlled clinical trials with strict safety monitoring.PMC+2ScienceDirect+2

19. Gene-targeted experimental drugs
    For some CMT subtypes, experimental treatments aim to correct gene expression or protein levels. For DYNC1H1-related forms like CMT2O, research is still mainly in early stages and lab models. These are not standard therapies and should only be accessed in research settings.PMC+2PubMed+2

20. Supportive medications for associated conditions
    People with CMT2O may also need medicines for scoliosis pain, orthopedic problems, bladder issues, or other comorbidities. Good overall control of health problems (for example, blood sugar, thyroid function) supports nerve health and quality of life even if it does not directly treat the genetic neuropathy.PMC+1

---

Dietary molecular supplements

Evidence for supplements in CMT2O specifically is limited. Most data come from other types of peripheral neuropathy. Always discuss supplements with a doctor to avoid interactions or overdosing.

1. Alpha-lipoic acid (ALA)
   Alpha-lipoic acid is an antioxidant that helps reduce oxidative stress in nerves. Trials in diabetic neuropathy show that ALA can modestly improve pain and nerve function in some patients, especially over several months. It is usually taken orally, and doses and duration must follow medical advice to avoid stomach upset or rare low blood sugar.PubMed+2MDPI+2

2. Acetyl-L-carnitine (ALC)
   ALC helps mitochondria produce energy and supports nerve repair. Systematic reviews show that ALC can reduce neuropathic pain and may support nerve fiber regeneration in diabetic and chemotherapy-induced neuropathy. It is generally well tolerated but should still be supervised by a doctor.PMC+2PLOS+2

3. Omega-3 fatty acids (EPA/DHA)
   Omega-3 fats from fish oil or algae have anti-inflammatory and neuroprotective actions. Animal and human studies suggest omega-3 supplements can support peripheral nerve structure and function and may reduce neuropathic symptoms in some conditions. Usual doses are based on general omega-3 guidelines and must consider bleeding risk and other medicines.PMC+2PubMed+2

4. Gamma-linolenic acid (GLA)
   GLA is an omega-6 fatty acid found in evening primrose and borage oil. Trials in diabetic neuropathy show some improvement in nerve symptoms, possibly through anti-inflammatory metabolites that support nerve blood flow and myelin health. Doses and duration must be individualized.e-dmj.org+1

5. B-complex vitamins (B1, B6, B12 – careful dosing)
   B vitamins are essential for nerve metabolism and myelin formation. Correcting deficiencies can improve nerve health and prevent additional neuropathy. However, very high long-term doses of B6 can themselves cause nerve damage, so B-complex products should only be used at safe levels guided by blood tests.PMC+1

6. Vitamin D
   Vitamin D supports bone, muscle, and immune health. Low levels are common in chronic illness and may worsen muscle weakness and pain. Supplementation in deficient people may improve overall function and reduce fracture risk, which is important for people with foot deformities and balance problems.PMC+1

7. Coenzyme Q10 (CoQ10)
   CoQ10 is involved in mitochondrial energy production. In some mitochondrial and neuromuscular disorders, CoQ10 supplementation can support energy levels and reduce fatigue. Evidence in CMT is limited, but it is sometimes tried under specialist supervision when fatigue is severe.PMC+1

8. Magnesium
   Magnesium influences muscle relaxation and nerve excitability. Correcting low magnesium can reduce cramps and improve sleep quality. Excessive intake, especially in kidney disease, can be dangerous, so any regular supplementation should be checked by blood tests.PMC+1

9. Curcumin (turmeric extract)
   Curcumin has anti-inflammatory and antioxidant effects in many experimental models. While direct CMT data are lacking, some patients with chronic pain conditions use standardized curcumin extracts as part of a broader anti-inflammatory lifestyle, always checking with their doctor about interactions and absorption enhancers like piperine.PubMed+1

10. N-acetylcysteine (NAC)
    NAC helps restore glutathione, an important antioxidant in cells. Preclinical studies suggest NAC can protect nerves from oxidative injury. Clinical evidence in hereditary neuropathies is still limited, so NAC should only be used under supervision, especially if other medicines or liver disease are present.PubMed+1

---

Immunity-booster, regenerative and stem-cell-related drugs

There are no FDA-approved stem-cell or gene-editing drugs specifically for CMT2O. The items below describe research directions and general supportive strategies, not standard treatments.

1. General immune optimization (vaccines, infection prevention)
   Keeping the immune system healthy with appropriate vaccines (such as influenza and pneumonia vaccines), good sleep, and treatment of infections helps avoid extra stress on already fragile nerves. This is routine preventive care, not a cure, but it lowers the chance of worsening symptoms due to illness.PMC+1

2. Experimental stem-cell therapies
   Early-phase studies are exploring mesenchymal or umbilical cord–derived stem cells to support nerve repair in CMT, with some reports of improved gait and balance. These treatments remain experimental, are not FDA-approved, and should only be received in regulated clinical trials, not in commercial “stem-cell clinics.”Cells4Life+2Wiley Online Library+2

3. Gene-therapy approaches
   Research in other CMT types (especially CMT1A) is testing gene-silencing and gene-replacement strategies to correct abnormal protein levels. Similar approaches may one day be adapted to DYNC1H1-related CMT2O, but no routine gene therapy is yet available, and safety issues are still being studied.PMC+2PMC+2

4. hiPSC-based regenerative research
   Scientists use human induced pluripotent stem cells (hiPSCs) derived from CMT patients to model disease and test candidate drugs in the lab. This research helps identify pathways that might be targeted for future regenerative medicines, but it is not directly available as treatment now.ScienceDirect+1

5. Neurotrophic-factor-based strategies
   Experimental therapies aim to deliver growth factors such as neurotrophin-3 or other molecules that support axon survival and myelination. So far, these have mainly been studied in animal models or very early human trials and are not standard care for CMT2O.PMC+2PubMed+2

6. Future small-molecule nerve-protective drugs
   New drugs, including HDAC6 inhibitors and other small molecules, are in development to protect axons and improve transport inside neurons. These are being tested in specific CMT types and may eventually offer regenerative benefits, but they are still in clinical trials and not available for routine use.PMC+2ScienceDirect+2

---

Surgeries

1. Soft-tissue releases and tendon lengthening
   Surgeons may lengthen tight calf or foot tendons and release contracted soft tissues to allow the foot to sit flatter in the shoe. This can improve walking comfort, reduce pain, and make it easier to wear braces and shoes.PMC+2ScienceDirect+2

2. Tendon transfers
   In tendon transfer surgery, a stronger tendon is moved to take over the job of a weak muscle, for example to lift the front of the foot. This can improve foot clearance and reduce tripping in people with severe foot drop that does not respond to braces.PMC+2ScienceDirect+2

3. Osteotomies (bone-cutting procedures)
   When the foot is very high-arched or twisted, bones can be cut and repositioned to create a more stable, plantigrade (flat) foot. This may reduce pain, improve balance, and slow progressive deformity, especially when done at the right stage of disease.PMC+2ScienceDirect+2

4. Joint fusion (arthrodesis)
   In severe deformities with unstable or painful joints, fusion surgery permanently joins bones to create a stable platform for walking. This sacrifices some movement but can significantly reduce pain and improve shoe wear in advanced cases.PMC+2ScienceDirect+2

5. Spine or other orthopedic surgeries
   If scoliosis or other skeletal deformities become severe and painful or threaten lung function, spinal fusion or other corrective surgeries may be considered. These decisions require careful team planning between neurologists, orthopedic surgeons, and rehabilitation specialists.PMC+2PubMed+2

---

Prevention and lifestyle

1. You cannot prevent the genetic change in CMT2O, but you can prevent complications such as falls, contractures, and skin ulcers through braces, therapy, and safe footwear.PMC+1

2. Avoid nerve-toxic medicines (for example, some chemotherapy drugs like vincristine) whenever possible; your doctors should always know that you have a hereditary neuropathy.PMC+2PubMed+2

3. Maintain a healthy body weight to reduce stress on weak feet and joints and to make walking, climbing stairs, and transfers easier.PMC+1

4. Do regular, gentle exercise (aerobic plus strengthening) tailored by a physiotherapist; this helps preserve strength and balance.PubMed+2ScienceDirect+2

5. Protect your feet by checking daily for blisters, cuts, or pressure spots, especially if sensation is reduced, and seeing a podiatrist early for problems.PMC+1

6. Use AFOs and other orthoses promptly when recommended, instead of waiting until falls or deformity become severe.PMC+2ScienceDirect+2

7. Do not smoke, because smoking damages blood vessels that supply nerves and may worsen neuropathic problems.PubMed+1

8. Keep chronic conditions such as diabetes or thyroid disease well controlled, because additional acquired neuropathy will make CMT symptoms worse.PMC+1

9. Maintain good mental health by seeking counseling or peer support early if you feel overwhelmed, which helps you stay engaged with therapy and self-care.ResearchGate+1

10. Stay in contact with a specialist CMT clinic or neurologist, so you can learn about new trials and updated management advice as research progresses.PMC+1

---

What to eat and what to avoid

1. Eat a varied, whole-food diet rich in fruits, vegetables, whole grains, lean protein, and healthy fats. This supports muscle health, immune function, and general energy levels.Verywell Health+1

2. Include omega-3-rich foods such as fatty fish (if culturally and medically appropriate), flaxseeds, or walnuts to support nerve and heart health.PubMed+1

3. Make sure you get enough B-vitamin sources (whole grains, legumes, eggs, dairy, fortified cereals) to support nerve metabolism, unless your doctor has told you to avoid certain foods.MedRxiv+1

4. Ensure adequate vitamin D and calcium intake through dairy, fortified plant milks, and safe sun exposure to maintain strong bones supporting weak muscles and joints.PubMed+1

5. Limit ultra-processed foods, fast food, and sugary drinks that can lead to weight gain and metabolic problems, putting extra strain on weak feet and nerves.PubMed+1

6. Avoid excessive alcohol, as it can damage nerves and worsen balance and judgment, increasing fall risk.PubMed+1

7. Moderate salt intake to support heart and blood-pressure health, especially if some pain medicines or other conditions affect the cardiovascular system.Verywell Health+1

8. Drink enough water to stay well hydrated, which supports energy and helps some people tolerate medicines better.PubMed+1

9. If you use dietary supplements, choose evidence-based products and avoid “miracle cures.” Always discuss them with your doctor to check for interactions and to confirm safe doses.PubMed+2Verywell Health+2

10. Work with a dietitian if you have weight problems, food restrictions, or other conditions like diabetes, so your diet can support nerve and muscle health without causing new issues.PMC+1

---

When to see a doctor

You should see a doctor or specialist urgently or promptly if:

• You notice new or rapidly worsening weakness, especially if you suddenly cannot walk, stand, or use your hands as before.PMC+1

• You develop severe or burning pain that does not improve with simple measures or begins to disturb sleep and daily function.PMC+1

• You have frequent falls, serious trips, or injuries, or your foot deformity suddenly worsens.PMC+1

• You see open sores, ulcers, or infections on your feet or legs, especially if you have reduced feeling and do not feel pain.PMC+1

• You or your family are planning a pregnancy and want genetic counseling about the risk of passing on CMT2O.MalaCards+1

• You feel very low, anxious, or hopeless, or you struggle to cope with the disease and need mental-health support.ResearchGate+1

---

Frequently asked questions

1. Is CMT2O the same as all other types of CMT?
   No. CMT2O is one specific axonal type of CMT caused by changes in the DYNC1H1 gene. Many features overlap with other types, but the exact gene, inheritance pattern, and sometimes age of onset or severity can differ.National Organization for Rare Disorders+1

2. Can CMT2O be cured today?
   At present there is no cure and no drug that stops or reverses the genetic problem. Treatment focuses on symptom control, maximizing function, and preventing complications while research explores gene and stem-cell-based options.PMC+2PubMed+2

3. Will everyone with CMT2O end up in a wheelchair?
   No. Many people remain able to walk, especially with braces, physiotherapy, and good foot care. Some may need a wheelchair or scooter for long distances, but this varies widely between individuals and families.PMC+1

4. Is exercise safe for CMT2O?
   Yes, when guided by a physiotherapist it is usually safe and helpful. Studies show that supervised strengthening and aerobic exercise can preserve or improve function without damaging nerves, as long as it is not excessive or painful.PubMed+2ScienceDirect+2

5. Can children with CMT2O play sports?
   Many children can take part in adapted physical activities and low-impact sports. The key is safety, avoiding high-risk contact sports, and using braces or supports when needed. A pediatric neurologist and physiotherapist can guide choices.PMC

6. Is pregnancy safe if I have CMT2O?
   Most people with CMT have safe pregnancies, but weakness and balance problems may worsen temporarily due to weight gain and hormonal changes. Obstetric and neurology teams should plan care together, and genetic counseling is important for family planning decisions.PMC+2PubMed+2

7. Will my children definitely inherit CMT2O?
   With autosomal dominant inheritance, each child has a 50% chance of inheriting the changed gene. Genetic counseling can explain this risk and discuss options such as prenatal or pre-implantation genetic testing, depending on local laws and personal values.MalaCards+1

8. Do pain medicines stop the disease from getting worse?
   No. Pain medicines only reduce symptoms. They do not change the underlying genetic damage or disease progression. However, good pain control can improve activity, sleep, and quality of life.PMC+2PMC+2

9. Are supplements like alpha-lipoic acid or omega-3 required?
   No supplement is required for everyone with CMT2O. Some have evidence in other neuropathies, but benefits in CMT are uncertain. Your doctor can help decide if any supplement is reasonable for you, based on blood tests and other conditions.PubMed+2PubMed+2

10. Is surgery always needed for foot deformities?
    No. Many people manage well with braces, shoes, and physiotherapy. Surgery is considered when deformity is severe, painful, or makes bracing and walking difficult. A foot and ankle surgeon with CMT experience can help decide.PMC+2ScienceDirect+2

11. Can gene therapy help me now?
    Gene therapy for CMT is still mainly in early research or very specific clinical trials, and not yet a routine treatment. Progress is promising, but it may take years before safe and effective options are widely available.PMC+2tmd.ac.jp+2

12. Are commercial “stem-cell clinics” safe for CMT2O?
    Most commercial clinics offering stem-cell “cures” for neuropathy are not supported by solid evidence and may be unsafe. Only regulated clinical trials or treatments approved by recognized authorities should be considered.Cells4Life+2Wiley Online Library+2

13. Can CMT2O affect breathing or heart function?
    CMT mainly affects peripheral nerves, but in some cases it can be associated with scoliosis, respiratory muscle weakness, or other complications. Regular monitoring by specialists helps detect and manage any such problems early.PMC+1

14. Is CMT2O life-threatening?
    Most forms of CMT, including many CMT2O cases, do not shorten life span, but they can cause significant disability and affect independence. Good rehabilitation, orthopedic care, and mental-health support are key to maintaining quality of life.PMC+2PubMed+2

15. What is the most important thing I can do right now?
    The most important steps are to work closely with a neurologist and rehabilitation team, use braces and physiotherapy as advised, protect your feet, stay active within safe limits, and maintain a healthy lifestyle. This combination gives the best chance of staying mobile and independent.PMC+2PubMed+2

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: December 22, 2025.